30/07/2024 - Institutional news
Dr. Arnau Busquets, coordinator of the Research Group on Cellular Mechanisms in Physiological and Pathological Behavior at the Hospital del Mar Research Institute, has been selected in the Leonardo grants to support science and culture of excellence, awarded by the BBVA Foundation. In total, 58 projects have been selected, 18 of which in Catalonia. The project led by Dr. Busquets, 'Identifying brain circuits involved in emotional recognition', has been one of the six winners in this edition in the category of Biology and Biomedicine. The aim of the project is to identify the specific brain circuits involved in empathy processes that may be involved in complex social deficits observed in some neurodevelopmental disorders or neurodegenerative diseases. To identify them, a specific mouse model and pharmacogenetic techniques will be used.
Més informació "The BBVA Foundation awards one of its Leonardo grants to Dr. Arnau Busquets."
19/06/2024 - Institutional news
Anna Bigas, coordinator of the Stem Cells and Cancer Group at the Hospital del Mar Research Institute, scientific director of CIBERONC, and deputy director of preclinical research at the Josep Carreras Institute, is part of the organizing committee. The event featured more than ten national and international speakers and 135 participants.
18/06/2024 - Institutional news
These are two international clinical trials, LAURA and ADRIATIC, which confirm the positive effect of consolidation with systemic therapies following the combination of chemotherapy in two patient populations.
22/05/2024 - Institutional news
From March 8 to June 28, hundreds of people will witness firsthand the advancements in scientific knowledge about various diseases, thanks to the drive of solidarity, in a new cycle of visits to research centers with projects funded by the La Marató de TV3 Foundation. At the Hospital del Mar Research Institute, we are participating in this initiative by organizing four visits where different projects funded by the 2021 Mental Health Marathon will be explained. On May 27 and 28, we will discuss the project led by Dr. Gabriel Santpere, who, together with Dr. Patricia Robledo, proposes a highly innovative methodology to predict the risk of developing schizophrenia. This will be done by combining information from nasal cavity neurons (olfactory neuroepithelium), genetics, and brain imaging from a group of people with and without symptoms of the disease. Registrations for the visits are free and can be made on this page:
Més informació "Once again we participate in "Visit the research of La Marató"."
15/05/2024 - Institutional news
The admission was approved at the meeting of the organization held on April 9th in Mannheim, Germany. The Research Institute of the Hospital del Mar is one of the five new members of the European Leukemia Net, an international network of excellence to promote cooperative research in different types of leukemias. Its admission was approved at the meeting of the organization held on April 9th in Mannheim, Germany. Dr. Blanca Espinet, coordinator of the Translational Research Group in Hematological Neoplasms and head of the Molecular Cytogenetics section of the Pathological Anatomy Service of Hospital del Mar, is the principal investigator representative of the center.
Més informació "The Research Institute of Hospital del Mar joins the European LeukemiaNet."
30/04/2024 - Institutional news
Researchers from the Neuroscience Research Program, in conjunction with the University of Minnesota in the United States, will conduct the first meta-analysis with individual data on this issue. They will analyze data from more than 30,000 people in the United States and four European countries. The aim is to obtain recommendations so that governments can establish dietary guidelines to prevent the onset of diseases such as Alzheimer's disease. Is there any type of diet that really works to prevent cognitive decline? Despite all the publications on this question, the scientific evidence is not conclusive. For this reason, the Institute for the Advancement of Foord and Nutrition Sciences (IAFNS), in the United States, a body that acts as an advisor to the US government, has commissioned the Hospital del Mar Research Institute and the Epidemiology and Community Health Division of the University of Minnesota School of Public Health to conduct the first meta-analysis with individual data on the question.
07/03/2024 - Institutional news
The PROMES-U study aims to evaluate the effectiveness of a guided online intervention in app format to reduce symptoms of depression and anxiety in university undergraduate students. This study is led by the Hospital del Mar Research Institute, with the participation of 6 Spanish universities: the UPF, the University of the Balearic Islands, the University Jaume I of Castellón, the University of Málaga, the University Miguel Hernández of Elche and the University of Zaragoza.
07/03/2024 - Institutional news
The association presented its grants today. 44 projects will benefit from an investment of more than 13.4 million euros.
26/02/2024 - Institutional news
This is a project funded by the European Union that aims to promote positive physical and mental health in the workplace in a changing environment. The Hospital del Mar Research Institute leads the PROSPERH project in the State, an initiative financed by EU-Horizon Europe, and formed by an international consortium of 21 partners from 19 countries. They will work together to develop and validate a multilevel intervention, aimed at work organizational aspects, individuals and their peers, the workers. It has three components focused on health promotion, self-management and online self-management, and indication of appropriate clinical care referral pathways.
23/02/2024 - Institutional news
A collaborative effort led by Dr. Anna Bigas, from the Hospital del Mar Research Institute and Josep Carreras Leukaemia Research Institute, found that the population of haematopoietic stem cells (HSC) responsible for the generation and self-renewal of the blood and immune system keeps a long-term undifferentiated state thanks to its ability to physically block its own NOTCH1 receptor through the expression of JAGGED1, a specific NOTCH activator. Authors hypothesise that the lack of this previously unknown mechanism might be the cause for the poor performance of current approaches to generate HSC from induced pluripotent stem cells for regenerative medicine.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
